Bupropion-amantadine-associated neurotoxicity.
Trappler
B
B
Miyashiro
A M
AM
D000368:Aged; D000369:Aged, 80 and over; D000547:Amantadine / Q000009:adverse effects* / Q000627:therapeutic use; D016642:Bupropion / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D003221:Confusion / Q000139:chemically induced; D003866:Depressive Disorder / Q000188:drug therapy / Q000453:epidemiology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology*
D016642:Bupropion; D000547:Amantadine